Yumanity therapeutics declared to work on neurodegenerative disease. Currently, there are almost 50 million people in this world who suffers from multiple kind of neurodegenerative disease.
The term neurodegenerative are used for several medical conditions that can affect the performance and structure of nerves. Such sort of continuous loss of structure and function lead to numerous other diseases such as Alzheimer, Huntington, ALS and Parkinson.
Unfortunately, scientists have failed to find a proper cure or treatment which can slow down the speed of neurodegenerative. The doctors merely prescribe drugs to patients which can treat the symptoms of neurodegenerative. They are still unaware of the method through which they can cut the root cause of these diseases. Hence, it makes treatment more complex task for patients. Patients have to spend a large amount of money only to decelerate the symptoms. As per the recent report, the yearly cost for the treatment of neurodegenerative disease is around $650
The chief aim of Yumanity Therapeutics is to battles with the unbearable ailments. The firm joined with a team of experts who are considered as specialists of this disease.
Tony Coles, the CEO of the company said that he love to work on big challenges. The appropriate treatment for this disease is usually considered as an impossible task.
The researchers inform that the first step is to carefully analyze the protein misfolding. Everyone knows that these neurodegenerative diseases emerge due to the cellular misfolding of proteins. Therefore, the scientists intend to closely examine the strands which are needed for the correct folding of protein.